improving treatments limited
improving treatments limited Company Information
Company Number
09521941
Registered Address
1 more london place, london, SE1 2AF
Industry
Other research and experimental development on natural sciences and engineering
Telephone
08000294540
Next Accounts Due
September 2024
Group Structure
View All
Shareholders
accellacare uk limited 100%
improving treatments limited Estimated Valuation
Pomanda estimates the enterprise value of IMPROVING TREATMENTS LIMITED at £0 based on a Turnover of £0 and 1.13x industry multiple (adjusted for size and gross margin).
improving treatments limited Estimated Valuation
Pomanda estimates the enterprise value of IMPROVING TREATMENTS LIMITED at £0 based on an EBITDA of £-3 and a 5.22x industry multiple (adjusted for size and gross margin).
improving treatments limited Estimated Valuation
Pomanda estimates the enterprise value of IMPROVING TREATMENTS LIMITED at £79 based on Net Assets of £100 and 0.79x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Improving Treatments Limited Overview
Improving Treatments Limited is a live company located in london, SE1 2AF with a Companies House number of 09521941. It operates in the other research and experimental development on natural sciences and engineering sector, SIC Code 72190. Founded in April 2015, it's largest shareholder is accellacare uk limited with a 100% stake. Improving Treatments Limited is a young, unknown sized company, Pomanda has estimated its turnover at £0 with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Improving Treatments Limited Health Check
There is insufficient data available to calculate a health check for Improving Treatments Limited. Company Health Check FAQs
0 Strong
0 Regular
0 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - Improving Treatments Limited
- - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Improving Treatments Limited
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- Improving Treatments Limited
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- Improving Treatments Limited
- - Industry AVG
Employees
There is insufficient data available for this Key Performance Indicator!
- - Improving Treatments Limited
- - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Improving Treatments Limited
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- Improving Treatments Limited
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Improving Treatments Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Improving Treatments Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Improving Treatments Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Improving Treatments Limited
- - Industry AVG
Debt Level
There is insufficient data available for this Key Performance Indicator!
- - Improving Treatments Limited
- - Industry AVG
IMPROVING TREATMENTS LIMITED financials
Improving Treatments Limited's latest turnover from December 2022 is estimated at 0 and the company has net assets of £100. According to their latest financial statements, we estimate that Improving Treatments Limited has no employees and maintains cash reserves of £100 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2022 | Dec 2021 | Dec 2020 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Apr 2016 | |
|---|---|---|---|---|---|---|---|---|
| Turnover | ||||||||
| Other Income Or Grants | ||||||||
| Cost Of Sales | ||||||||
| Gross Profit | ||||||||
| Admin Expenses | ||||||||
| Operating Profit | ||||||||
| Interest Payable | ||||||||
| Interest Receivable | ||||||||
| Pre-Tax Profit | ||||||||
| Tax | ||||||||
| Profit After Tax | ||||||||
| Dividends Paid | ||||||||
| Retained Profit | ||||||||
| Employee Costs | ||||||||
| Number Of Employees | ||||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2022 | Dec 2021 | Dec 2020 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Apr 2016 | |
|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 100 | 100 | 100 | 100 | 0 | 0 | 0 | 0 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 100 | 100 | 100 | 100 | 0 | 0 | 0 | 0 |
| total assets | 100 | 100 | 100 | 100 | 0 | 0 | 0 | 0 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| net assets | 100 | 100 | 100 | 100 | 0 | 0 | 0 | 0 |
| total shareholders funds | 100 | 100 | 100 | 100 | 0 | 0 | 0 | 0 |
| Dec 2022 | Dec 2021 | Dec 2020 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Apr 2016 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Operating Profit | ||||||||
| Depreciation | 0 | 0 | 0 | 0 | ||||
| Amortisation | 0 | 0 | 0 | 0 | ||||
| Tax | ||||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | ||||||||
| Investing Activities | ||||||||
| capital expenditure | ||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | ||||||||
| Financing Activities | ||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||
| interest | ||||||||
| cash flow from financing | ||||||||
| cash and cash equivalents | ||||||||
| cash | 0 | 0 | 100 | 100 | 0 | 0 | 0 | 0 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 0 | 0 | 100 | 100 | 0 | 0 | 0 | 0 |
improving treatments limited Credit Report and Business Information
Improving Treatments Limited Competitor Analysis
Perform a competitor analysis for improving treatments limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other young companies, companies in SE1 area or any other competitors across 12 key performance metrics.
improving treatments limited Ownership
IMPROVING TREATMENTS LIMITED group structure
Improving Treatments Limited has no subsidiary companies.
Ultimate parent company
ICON INVESTMENTS LTD
#0120551
2 parents
IMPROVING TREATMENTS LIMITED
09521941
improving treatments limited directors
Improving Treatments Limited currently has 4 directors. The longest serving directors include Mr Paul Talini (May 2019) and Mr Paul Talini (May 2019).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Paul Talini | 40 years | May 2019 | - | Director | |
| Mr Paul Talini | 40 years | May 2019 | - | Director | |
| Mr Brendan Harte | United Kingdom | 59 years | Aug 2019 | - | Director |
| Emer Lyons | England | 46 years | Oct 2023 | - | Director |
P&L
December 2022turnover
0
0%
operating profit
-3.5
0%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2022net assets
100
0%
total assets
100
0%
cash
100
0%
net assets
Total assets minus all liabilities
Similar Companies
improving treatments limited company details
company number
09521941
Type
Private limited with Share Capital
industry
72190 - Other research and experimental development on natural sciences and engineering
incorporation date
April 2015
age
9
incorporated
UK
accounts
Dormant
ultimate parent company
previous names
N/A
last accounts submitted
December 2022
address
1 more london place, london, SE1 2AF
accountant
-
auditor
-
improving treatments limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to improving treatments limited.
improving treatments limited Companies House Filings - See Documents
| date | description | view/download |
|---|
